Financial insights of EMED

MyFinsight

Income Statement	2024-09-30	2024-06-30
Net sales	42,526	237,645
Cost of sales	11,881	64,390
Us-gaap_grossprofit	30,645	173,255
Selling, general and administrative expenses	411,683	425,100
Us-gaap_operatingincomeloss	-381,038	-251,845
Interest expense	NaN	58,301
Derivative, gain (loss) on derivative, net	NaN	121,319
The amount of change in fair value of derivative liabilities	NaN	-337,439
Amount of income expenses related to other non operating activities	NaN	82,624
Us-gaap_interestexpensenonoperating	54,914	NaN
Us-gaap_othernonoperatingincomeexpense	3,521	483,081
Us-gaap_gainlossonderivativeinstrumentsnetpretax	46,486	NaN
Change in fair value of derivative liabilities	-338,698	NaN
Us-gaap_nonoperatingincomeexpense	-343,605	NaN
Net loss	-724,643	231,236
Us-gaap_netincomelossavailabletocommonstockholdersbasic	-724,643	231,236

Basic EPS	0	0
Diluted EPS	NaN	0
Basic Average Shares	681,000,979	566,665,842
Diluted Average Shares	NaN	1,943,580,744

Unit: Dollar. Numbers labeled with * are estimated quarterly values.